|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
For human use
|
|
Package code:
|
1112409
|
|
Name of medicinal product:
|
AMIOKORDIN
|
|
Active substances:
|
|
|
ATC code:
|
C01BD01
|
|
Dosage form:
|
solution for injection
|
|
Route of administration:
|
intravenous use
|
|
Strengh:
|
50mg 1ml
|
|
Amount in package:
|
3ml 5TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Paroxysmal supraventricular tachycardia (including Wolff-Parkinson-White syndrome), atrial fibrillation and flutter, ventricular tachyarrhythmias, when other drugs are ineffective, contraindicated or have caused severe adverese reactions.
Note: Amiokordin solution for injection is used only when rapid response to treatment is required or when oral treatment is not possible.
|
|
Safety features:
|
Yes
|
|
Summary of product characteristics (SPC):
|
 (last updated March 28, 2022)
|
|
Package information leaflet (PIL):
|
EST (last updated March 28, 2022)
|
|
Labelling:
|
(last updated October 6, 2020)
|
|
Last imported to Estonia:
|
November 27, 2023
|
|
Marketing authorization holder:
|
KRKA d.d. Novo mesto
|
|
Marketing authorization number:
|
418003
|
|
Marketing authorization issued on:
|
August 8, 2003
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
|
Reference price:
|
|
|
Under reference price:
|
|
|
Reference price of daily dose:
|
|
Entry/Changing date:
August 7, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere